Central Labs provides a range of late-stage laboratory services to global clients, including standardized assays, cardiac services, integrated data management, international laboratory study co-ordination and site support from 600 employees at six sites in Europe, North America and Asia. "The completion of this transaction supports the Company's strategy to focus on its MDS Nordion business," said Stephen P. DeFalco, President and Chief Executive Officer of MDS Inc. "MDS Nordion remains committed to innovation and operational excellence to further build its leadership positions in the provision of medical isotopes for molecular and diagnostic imaging, radiotherapeutics and sterilization technologies." The transaction is expected to close in the fourth calendar quarter of 2009, and is subject to customary approvals and closing conditions. In addition, the sale of the Central Labs operations in France and Germany is subject to review and consultation with the applicable Works Councils in accordance with labour laws in those countries. ((Comments on this story may be sent to newsdesk@closeupmedia.com)) For full details on Mds Incorporated (MDZ) click here. Mds Incorporated (MDZ) has Short Term PowerRatings of 6. Details on Mds Incorporated (MDZ) Short Term PowerRatings is available at This Link.
![]()
Email Print Archives Feedback Email Article Link
Close X
Related News [MDZ]
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Wednesday December 2 04:30 PM
Thursday December 3 12:30 PM
Wednesday December 2 01:00 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
|